The role of colonization pressure in the dissemination of colistin or tigecycline resistant KPC-producing Klebsiella pneumoniae in critically ill patients

Infection

Volumn 42, Issue 5, 2014, Pages 883-890

  Papadimitriou Olivgeris, M ^a   Christofidou, M ^a   Fligou, F ^a   Bartzavali, C ^a   Vrettos, T ^a   Filos, K S ^a   Marangos, M ^a   Anastassiou, E D ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Carbapenemase; Carriage; Intensive Care Unit; Resistance epidemiology; Surveillance

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE; COLISTIN; MINOCYCLINE; TIGECYCLINE;

ADULT; AGED; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENETICS; GREECE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; TRANSMISSION; UNIVERSITY HOSPITAL;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GREECE; HOSPITALIZATION; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; MINOCYCLINE; PROSPECTIVE STUDIES; RISK FACTORS; TERTIARY CARE CENTERS;

EID: 84918828976     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-014-0653-x     Document Type: Article

References (27)

1. Maltezou HC, Giakkoupi P, Maragos A, et al. Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect. 2009;58:213–9.
2. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis. 2013;77:169–73.
3. Giakkoupi P, Papagiannitsis CC, Miriagou V, et al. An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10). J Antimicrob Chemother. 2011;66:1510–3.
4. Giakoupi P, Maltezou H, Polemis M, et al. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 2009;14. pii:19218.
5. Grundmann H, Livermore DM, Giske CG, et al. Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill. 2010;15. pii:19711.
6. European Centre for Disease Prevention and Control (ECDC). Antimicrobial resistance surveillance in Europe 2012. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC; 2013.
7. Kontopidou F, Giamarellou H, Katerelos P, et al. Infections caused by carbapenem-resistant Klebsiella pneumoniae among patients in intensive care units in Greece: a multi-centre study on clinical outcome and therapeutic options. Clin Microbiol Infect. 2014;20:O117–23. doi:10.1111/1469-0691.12341.
8. Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55:943–50.
9. Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56:2108–13.
10. da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert Opin Biol Ther. 2012;12:663–71.
11. Markou N, Apostolakos H, Koumoudiou C, et al. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients. Crit Care. 2003;7:R78–83.
12. Valentin-Martin A, Valverde-De Francisco A, Bosque-Vall M, et al. First report of colistin-resistant KPC-2 producing ST258-Klebsiella pneumoniae in Spain. Enferm Infect Microbiol Clin. 2013;31:489–91. doi:10.1016/j.eimc.2012.12.002.
13. Kontopidou F, Plachouras D, Papadomichelakis E, et al. Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients. Clin Microbiol Infect. 2011;17:E9–11. doi:10.1111/j.1469-0691.2011.03649.x.
14. Nigo M, Cevallos CS, Woods K, et al. Nested case-control study of the emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother. 2013;57:5743–6.
15. Clinical and Laboratory Standards Institute (CLSI). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 12th edn. Approved standard M7-A7. Wayne: CLSI; 2011.
16. The European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1; 2013. http://www.eucast.org. Accessed 24 Mar 2014.
17. Tsakris A, Poulou A, Pournaras S, et al. A simple phenotypic method for the differentiation of metallo-b-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates. J Antimicrob Chemother. 2010;65:1664–71.
18. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev. 2007;20:440–58.
19. Papadimitriou-Olivgeris M, Marangos M, Fligou F, et al. Risk factors for KPC-producing Klebsiella pneumoniae enteric colonization upon ICU admission. J Antimicrob Chemother. 2012;67:2976–81.
20. Lubbert C, Faucheux S, Becker-Rux D, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013;42:565–70. doi:10.1016/j.ijantimicag.2013.08.008.
21. Halaby T, al Naiemi N, Kluytmans J, et al. Emergence of colistin resistance in Enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit. Antimicrob Agents Chemother. 2013;57:3224–9.
22. Bonten MJ. Colonization pressure: a critical parameter in the epidemiology of antibiotic-resistant bacteria. Crit Care. 2012;16:142.
23. Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect. 2013;. doi:10.1016/j.medmal.2013.11.007.
24. Tacconelli E, Cataldo MA, Dancer SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20(Suppl 1):1–55. doi:10.1111/1469-0691.12427.
25. North RJ. The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci. J Exp Med. 1971;134:1485–500.
26. Moreira LL, Netto EM, Nascimento-Carvalho CM. Use of corticosteroid is a risk factor for nosocomial infection in paediatric patients. J Hosp Infect. 2009;71:287–8.
27. Genoni G, Prodam F, Marolda A, et al. Obesity and infection: two sides of one coin. Eur J Pediatr. 2014;173:25–32. doi:10.1007/s00431-013-2178-1.